Capital Cs Group, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Capital Cs Group, LLC

  • $146 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 07, 2023
BUY
$680.49 - $826.97 $266,752 - $324,172
392 New
392 $322,000
Q4 2021

Jan 20, 2022
SELL
$543.48 - $670.97 $614,132 - $758,196
-1,130 Closed
0 $0
Q3 2021

Oct 13, 2021
BUY
$574.03 - $680.96 $648,653 - $769,484
1,130 New
1,130 $645,000

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Capital Cs Group, LLC Portfolio

Follow Capital Cs Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Cs Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Cs Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email